Table 1.
Ref. | Species | Crystal main compounds | Crystals location | Animal Model | Read out | Urinary phenotype | Renal injury |
Tawashi et al[17], 1980 | Rats | CaOx | Tubules | HyP injection i.p. (10 mL/kg), | 1 d | Hyperoxaluria | Kidney dilatation, oedema |
Khan et al[8], 1982 | Rats | CaOx | Tubules, interstitium, papillary tips | Sodium oxalate Injection (7 mg/100 g body weight) | 1 h | Hyperoxaluria | Tubular obstruction and dilatation |
Marengo et al[6], 2004 | Rats | COM crystals | Tubules (cortex, medulla) | potassium oxalate SC (Minipump) | 14 d | Hyperoxaluria | Tubular injury, dilatation, regeneration, interstitial inflammation |
Vervaet et al[10], 2009 | Rats | COM crystals | Tubules | Ethylene glycol (0.75%) | 1-6 d | Hyperoxaluria | Tubular injury, dilatation and regeneration, interstitial inflammation |
Khan et al[16], 2006 | Rats | CaOx | Tubules (cortex, medulla), Papillary tips (plaques § stones) | 5% Hyp supplement | 28 d | Hyperoxaluria | Inflammation, tubular injury |
Mo et al[20], 2004 | Mice | CaOx | Collecting ducts (medulla, papilla) | Tamm-Horsfall KO mice | 2-4 mo | ND | |
Chau et al[23], 2003 | Mice | -CaP | Tubules (cortex, medulla), Papilla | Npt2 KO mice + HyP supplement (4 wk) | From birth | Hypercalciuria, Hyperphosphaturia | ND |
Knight et al[24], 2012 | Mice | CaOx (COM + COD) | Tubules (Cortex, medulla) interstitium | GRHPR KO mice | After 4 wk (HyP supplements) | Hyperoxaluria | ND |
CaP: Calcium phosphate; CaOx: Calcium oxalate; COM: Calcium oxalate monohydrate; COD: Calcium oxalate dihydrate.